TY - JOUR T1 - Smoking and subfertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study JF - medRxiv DO - 10.1101/2021.10.25.21265469 SP - 2021.10.25.21265469 AU - Álvaro Hernáez AU - Robyn E. Wootton AU - Christian M. Page AU - Karoline H. Skåra AU - Abigail Fraser AU - Tormod Rogne AU - Per Magnus AU - Pål R. Njølstad AU - Ole A. Andreassen AU - Stephen Burgess AU - Deborah A. Lawlor AU - Maria Christine Magnus Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/25/2021.10.25.21265469.abstract N2 - Objective To investigate the association between smoking-related traits and subfertility.Design Prospective study.Setting Nationwide cohort in Norway.Patients 28,606 women (average age 30) and 27,096 men (average age 33) with questionnaire and genotype information from the Norwegian Mother, Father and Child Cohort Study.Intervention Self-reported information on smoking (having ever smoked [both sexes], age at smoking initiation [women only], smoking cessation [women only], and cigarettes smoked per week in current smokers [both sexes]) was gathered. Genetically predetermined levels or likelihood of presenting the mentioned traits were estimated for Mendelian randomization (MR) analyses.Main outcome measure Subfertility, defined as time-to-pregnancy ≥12 months.Results A total of 10% of couples were subfertile. In multivariable regression accounting for age, years of education, body mass index, and number of previous pregnancies, having ever smoked was not linked to subfertility in women or men. A higher intensity of tobacco use in women who were current smokers was related to greater odds of subfertility (+ 1 standard deviation [SD, 48 cigarettes/week]: odds ratio [OR] 1.12, 95% confidence interval [CI] 1.03 to 1.21), also after adjusting for the partner’s tobacco use. Later smoking initiation (+ 1 SD [3.2 years]: OR 0.89, 95% CI 0.84 to 0.95) and smoking cessation (relative to not quitting: OR 0.83, 95% CI 0.75 to 0.93) were linked to decreased subfertility in women who had ever smoked. Nevertheless, MR results were not directionally consistent for smoking intensity and cessation and were imprecisely estimated in two-sample MR, with wide confidence intervals that overlapped with the multivariable regression results. In men, greater smoking intensity was marginally linked to greater odds of subfertility in multivariable analyses, but this association was attenuated when adjusting for the partner’s smoking intensity (+ 1 SD [54 cigarettes/week]: OR 1.05, 95% CI 0.96 to 1.15). MR estimates were directionally consistent but again imprecisely estimated.Conclusions We did not find robust evidence of an effect of smoking on subfertility. This may be due to a true lack of effect, weak genetic instruments, or other kinds of confounding. The relevant limitations across all methods highlights the need for larger studies with information on subfertility.Competing Interest StatementD.A.L. receives (or has received in the last 10 years) research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. The rest of the authors declare that no competing interests exist.Funding StatementThe MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This project received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement No 947684). This work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700, and the project 'Women's fertility - an essential component of health and well-being', number 320656. Open Access funding was provided by the Folkehelseinstituttet/Norwegian Institute of Public Health. D.A.L. is a UK National Institute for Health Research Senior Investigator (NF-SI-0611-10196) and is supported by the US National Institutes of Health (R01 DK10324) and a European Research Council Advanced Grant (grant agreement No 669545). The funders had no role in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ETHICAL APPROVAL The MoBa cohort is conducted according to the Declaration of Helsinki for Medical Research involving Human Subjects. The establishment of MoBa and initial data collection was based on a license from the Norwegian Data Protection Agency. It is now based on regulations related to the Norwegian Health Registry Act. Participants provided a written informed consent before joining the cohort. This project was approved by the Regional Committee for Medical and Health Research Ethics of South/East Norway (reference: 2017/1362). ACKNOWLEDGEMENTS The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We thank all the participating families in Norway who take part in this ongoing cohort study, and those who contributed to the recruitment and the infrastructure of the cohort. We thank the Norwegian Institute of Public Health for generating high-quality genomic data. This research is part of the HARVEST collaboration, supported by the Research Council of Norway (project reference: #229624). We also thank the NORMENT Centre for providing genotype data, funded by the Research Council of Norway (project reference: #223273), South East Norway Health Authority, and Stiftelsen Kristian Gerhard Jebsen. We further thank the Center for Diabetes Research (University of Bergen) for providing genotype information and performing quality control and imputation of the data in research projects funded by the European Research Council Advanced Grant SELECTionPREDISPOSED, Stiftelsen Kristian Gerhard Jebsen, the Trond Mohn Foundation, the Research Council of Norway, the Novo Nordisk Foundation, the University of Bergen, and the Western Norway Health Authority. This work was performed on the TSD (Tjeneste for Sensitive Data) facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (tsd-drift@usit.uio.no). This paper does not necessarily reflect the position or policy of the Norwegian Research Council.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesConsent given by the participants does not open for storage of data on an individual level in repositories or journals. Researchers who want access to datasets for replication should submit an application to datatilgang{at}fhi.no. Access to datasets requires approval from the Regional Committee for Medical and Health Research Ethics in Norway and an agreement with MoBa. Source data of the GWAS on smoking initiation, age of smoking initiation, smoking cessation, and smoking intensity) are available in the Supplemental Tables of the article by Liu M et al. (published in Nat Genet in 2019: https://www.nature.com/articles/s41588-018-0307-5#Sec14). Source data of the GWAS on education years are available in the Supplemental Tables of the article by Lee JJ et al. (published in Nat Genet in 2018: https://www.nature.com/articles/s41588-018-0147-3#Sec34). Finally, source data of the GWAS on BMI (Yengo L et al., Hum Mol Genet, 2018) are available in the GIANT Consortium website (https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files#GWAS_Anthropometric_2015_BMI_Summary_Statistics). ER -